Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Translational Lung Cancer Research|March 15, 2021
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinomaXuefeng Leng, Shiyou Wei, Jiandong Mei, et al.
Journal of Clinical Medicine|April 11, 2020
Concomitant <i>TP53</i> Mutation Confers Worse Prognosis in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.
Virchows Archiv : an International Journal of Pathology|November 19, 2018
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implicationsMartina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Frontiers in Immunology|June 16, 2020
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic ToolMartina Mandarano, Guido Bellezza, Maria Laura Belladonna, et al.
Future Oncology (London, England)|March 22, 2023
Combi-TED: a new trial testing Tedopi<sup>®</sup> with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first lineLorenza Landi, Angelo Delmonte, Andrea Bonetti, et al.
Translational Lung Cancer Research|January 24, 2022
PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasmKai-Fu Zheng, Yu-Jian Liu, Nan Ma, et al.
Pageof 17